OGN

Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Organon & Co. (OGN) Shareholder/Analyst Call - Slideshow (NYSE:OGN) 2026-06-17

Organon (OGN) Stock After New TOFIDENCE Approval A Fresh Look At Valuation And Recovery Potential

Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19

Organon wins US approval to widen use of arthritis biosimilar drug

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know